{"abstract": "In the wake of Baxter\u2019s split, Merck, Bayer and Johnson & Johnson may find it hard not to jump on the bandwagon, says Robert Cyran of Reuters Breakingviews.", "web_url": "https://dealbook.nytimes.com/2014/03/27/conscious-uncoupling-for-drug-makers/", "snippet": "In the wake of Baxter\u2019s split, Merck, Bayer and Johnson & Johnson may find it hard not to jump on the bandwagon, says Robert Cyran of Reuters Breakingviews.", "lead_paragraph": "Baxter International has put conscious uncoupling on pharma\u2019s radar.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/03/28/business/dbpix-baxter2/dbpix-baxter2-jumbo.jpg", "height": 374, "width": 523, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/03/28/business/dbpix-baxter2/dbpix-baxter2-superJumbo.jpg", "height": 374, "width": 523, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/03/28/business/dbpix-baxter2/dbpix-baxter2-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/03/28/business/dbpix-baxter2/dbpix-baxter2-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/03/28/business/dbpix-baxter2/dbpix-baxter2-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Conscious Uncoupling for Drug Makers", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Biotechnology", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Baxter International", "rank": 4, "major": "N"}], "pub_date": "2014-03-27T18:42:39+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Robert Cyran", "person": [{"firstname": "Robert", "middlename": null, "lastname": "Cyran", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/dffcc012-2fc0-597c-8c34-95bbdf1e8405", "word_count": 354, "uri": "nyt://article/dffcc012-2fc0-597c-8c34-95bbdf1e8405"}